Search for a trial

A single-arm trial to evaluate the effectiveness of PCI of de novo 3-vessel disease
applying the SYNTAX Score II with pressure wire functional assessment and
IVUS guidance, using an everolimus-eluting stent with biodegradable abluminal
coating

* To evaluate the effectiveness of contemporary PCI treatment of de novo 3-vessel disease following the heart team selection applying the SYNTAX Score II with pressure wire functional assessment and IVUS guidance (SYNTAX II strategy).* To establish…

eOPTIMA Registry

The primairy objective of this study is to evaluate the safety and efficacy of the Janus OPTIMA stent in the treatment of the novo lesions in native cotronary arteries with a maximum lenght of 28 mm and a diameter of 2.5 - 4.0 mm